PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IRMD vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between IRMD and SPY is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

IRMD vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IRadimed Corporation (IRMD) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
28.16%
10.44%
IRMD
SPY

Key characteristics

Sharpe Ratio

IRMD:

0.89

SPY:

1.88

Sortino Ratio

IRMD:

1.39

SPY:

2.53

Omega Ratio

IRMD:

1.17

SPY:

1.35

Calmar Ratio

IRMD:

1.30

SPY:

2.83

Martin Ratio

IRMD:

5.50

SPY:

11.74

Ulcer Index

IRMD:

4.88%

SPY:

2.02%

Daily Std Dev

IRMD:

30.29%

SPY:

12.64%

Max Drawdown

IRMD:

-75.83%

SPY:

-55.19%

Current Drawdown

IRMD:

-8.82%

SPY:

-0.42%

Returns By Period

In the year-to-date period, IRMD achieves a 3.89% return, which is significantly lower than SPY's 4.15% return. Over the past 10 years, IRMD has outperformed SPY with an annualized return of 15.44%, while SPY has yielded a comparatively lower 13.18% annualized return.


IRMD

YTD

3.89%

1M

-5.29%

6M

28.16%

1Y

33.22%

5Y*

17.39%

10Y*

15.44%

SPY

YTD

4.15%

1M

1.22%

6M

10.44%

1Y

24.34%

5Y*

14.62%

10Y*

13.18%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IRMD vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IRMD
The Risk-Adjusted Performance Rank of IRMD is 7575
Overall Rank
The Sharpe Ratio Rank of IRMD is 7575
Sharpe Ratio Rank
The Sortino Ratio Rank of IRMD is 6868
Sortino Ratio Rank
The Omega Ratio Rank of IRMD is 6565
Omega Ratio Rank
The Calmar Ratio Rank of IRMD is 8383
Calmar Ratio Rank
The Martin Ratio Rank of IRMD is 8383
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 7878
Overall Rank
The Sharpe Ratio Rank of SPY is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 7575
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 7878
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 7979
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8282
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IRMD vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for IRadimed Corporation (IRMD) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for IRMD, currently valued at 0.89, compared to the broader market-2.000.002.000.891.88
The chart of Sortino ratio for IRMD, currently valued at 1.39, compared to the broader market-4.00-2.000.002.004.006.001.392.53
The chart of Omega ratio for IRMD, currently valued at 1.17, compared to the broader market0.501.001.502.001.171.35
The chart of Calmar ratio for IRMD, currently valued at 1.30, compared to the broader market0.002.004.006.001.302.83
The chart of Martin ratio for IRMD, currently valued at 5.50, compared to the broader market-10.000.0010.0020.0030.005.5011.74
IRMD
SPY

The current IRMD Sharpe Ratio is 0.89, which is lower than the SPY Sharpe Ratio of 1.88. The chart below compares the historical Sharpe Ratios of IRMD and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
0.89
1.88
IRMD
SPY

Dividends

IRMD vs. SPY - Dividend Comparison

IRMD's dividend yield for the trailing twelve months is around 0.79%, less than SPY's 1.16% yield.


TTM20242023202220212020201920182017201620152014
IRMD
IRadimed Corporation
0.79%0.82%3.54%3.53%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.16%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

IRMD vs. SPY - Drawdown Comparison

The maximum IRMD drawdown since its inception was -75.83%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for IRMD and SPY. For additional features, visit the drawdowns tool.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%SeptemberOctoberNovemberDecember2025February
-8.82%
-0.42%
IRMD
SPY

Volatility

IRMD vs. SPY - Volatility Comparison

IRadimed Corporation (IRMD) has a higher volatility of 11.54% compared to SPDR S&P 500 ETF (SPY) at 2.93%. This indicates that IRMD's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%SeptemberOctoberNovemberDecember2025February
11.54%
2.93%
IRMD
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab